Overview
Investing at the convergence of biology and computing.
Deals · 12mo
2
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Lightcast Discovery | Apr 2026Participated | $27 MOther Equity | |
Syndex Bio | Feb 2026Participated | $16 MSeed | |
MRM Health | Sep 2025Participated | $64 MSeries B | |
Constructive Bio | Sep 2024Led | $58 MSeries A | |
OverT Bio | May 2024Participated | $16 MSeed | |
Tagomics | Feb 2024Participated | $8 MOther Equity | |
Freya Biosciences | Dec 2023Led | $38 MSeries A | |
Aperiam Bio | Nov 2023Led | $9 MSeed | |
VedaBio | Oct 2023Led | $40 MOther Equity | |
Lightcast Discovery | Aug 2023Participated | $49 MSeries B | |
Constructive Bio | Aug 2022Participated | $15 MSeed | |
Replay | Jul 2022Led | $55 MSeed | |
Lightcast Discovery | Apr 2026Participated | $27 MOther Equity | |
Syndex Bio | Feb 2026Participated | $16 MSeed | |
MRM Health | Sep 2025Participated | $64 MSeries B | |
Constructive Bio | Sep 2024Led | $58 MSeries A | |
OverT Bio | May 2024Participated | $16 MSeed | |
Tagomics | Feb 2024Participated | $8 MOther Equity | |
Freya Biosciences | Dec 2023Led | $38 MSeries A | |
Aperiam Bio | Nov 2023Led | $9 MSeed | |
VedaBio | Oct 2023Led | $40 MOther Equity | |
Lightcast Discovery | Aug 2023Participated | $49 MSeries B | |
Constructive Bio | Aug 2022Participated | $15 MSeed | |
Replay | Jul 2022Led | $55 MSeed |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 3 | 3 |
| Series A | 4 | 1 |
| Series B | 0 | 3 |
| Series C+ | 0 | 1 |
| Other Equity | 1 | 2 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Jun '20 | 1 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 1 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 1 |
| Aug '21 | 0 |
| Sep '21 | 1 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 1 |
| Jan '22 | 0 |
| Feb '22 | 1 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 1 |
| Aug '22 | 1 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 1 |
| Sep '23 | 0 |
| Oct '23 | 1 |
| Nov '23 | 1 |
| Dec '23 | 1 |
| Jan '24 | 0 |
| Feb '24 | 1 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 1 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 1 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 1 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 1 |
| Mar '26 | 0 |
| Apr '26 | 1 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 18 |
| AI & Machine Learning | 2 |
| Consumer & Lifestyle | 2 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 3 |
| $10M-$25M | 4 |
| $25M-$50M | 5 |
| $50M-$100M | 5 |
| $100M-$250M | 1 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 11 |
| Europe | 7 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| ARTIS Ventures | 4 |
| NanoDimension | 4 |
| ARCH Venture Partners | 3 |
| Civilization Ventures | 3 |
| Illumina Ventures | 3 |
| Ahren Innovation Capital | 2 |
| Alexandria Venture Investments | 2 |
| Axial VC | 2 |
| LifeForce Capital | 2 |
| Longwall Ventures | 2 |
| M Ventures | 2 |
| Meltwind | 2 |
| Vertical Venture Partners | 2 |
| Wing Venture Capital | 2 |
| Ackermans & van Haaren | 1 |
| Agilent Technologies | 1 |
| Amadeus Capital Partners | 1 |
| Angelini Ventures | 1 |
| Apeiron Investment Group | 1 |
| ATHOS | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 8 | 44% |
| Participating | 10 | 56% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 3 | 38% |
| Co-led | 5 | 63% |
Team
Managing Director & Co-Founder
Managing Director & Co-Founder
Vice President
Managing Director & Co-Founder